Rice Hall James & Associates’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Rice Hall James & Associates’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-51,902	Closed	-$2.14M	–	333
2015 Q2	$2.14M	Sell	51,902 -104,910	-67%	-$3.76M	0.12%	183
2015 Q1	$5.53M	Buy	156,812 +137,850	+727%	+$4.66M	0.32%	87
2014 Q4	$609K	Buy	18,962 +263	+1%	+$7.61K	0.04%	262
2014 Q3	$525K	Buy	18,699 +232	+1%	+$7.07K	0.04%	262
2014 Q2	$558K	Buy	18,467 +261	+1%	+$7.2K	0.04%	262
2014 Q1	$504K	Buy	18,206 +727	+4%	+$19K	0.04%	264
2013 Q4	$446K	Buy	+17,479	New	+$539K	0.03%	265

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Rice Hall James & Associates's BRLI Position: Q3 2015 in Review

Rice Hall James & Associates sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 51,902 shares — an estimated $2.14M sold.

Rice Hall James & Associates first reported a position in BRLI in Q4 2013 and held it in 7 quarters. The position peaked at $5.53M in Q1 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Rice Hall James & Associates reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Rice Hall James & Associates sold 51,902 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $2.14M.
Rice Hall James & Associates first reported a position in BIO-REFERENCE LABS INC-NEW- in Q4 2013 and held it in 7 quarters.
Rice Hall James & Associates's BIO-REFERENCE LABS INC-NEW- position peaked at $5.53M in Q1 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Rice Hall James & Associates's 13F filing for Q3 2015, filed 30 Oct 2015.